(Q40287632)

English

Rapid and massive expansion of cord blood-derived cytokine-induced killer cells: an innovative proposal for the treatment of leukemia relapse after cord blood transplantation

scientific article published on 18 September 2006

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

19 September 2017

Rapid and massive expansion of cord blood-derived cytokine-induced killer cells: an innovative proposal for the treatment of leukemia relapse after cord blood transplantation (English)

1 reference

Europe PubMed Central

19 September 2017

author name string

Introna M

1

1 reference

Europe PubMed Central

19 September 2017

Franceschetti M

2

1 reference

Europe PubMed Central

19 September 2017

Ciocca A

3

1 reference

Europe PubMed Central

19 September 2017

Borleri G

4

1 reference

Europe PubMed Central

19 September 2017

Conti E

5

1 reference

Europe PubMed Central

19 September 2017

Golay J

6

1 reference

Europe PubMed Central

19 September 2017

Rambaldi A

7

1 reference

Europe PubMed Central

19 September 2017

language of work or name

0 references

publication date

18 September 2006

1 reference

Europe PubMed Central

19 September 2017

Bone Marrow Transplantation

1 reference

Europe PubMed Central

19 September 2017

38

1 reference

Europe PubMed Central

19 September 2017

9

1 reference

Europe PubMed Central

19 September 2017

621-627

1 reference

Europe PubMed Central

19 September 2017

https://scigraph.springernature.com/pub.10.1038/sj.bmt.1705503

0 references

Umbilical cord blood transplantation: a new alternative option.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705503

21 January 2018

Cord blood immunology and stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705503

21 January 2018

Outcomes after transplantation of cord blood or bone marrow from unrelated donors in adults with leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705503

21 January 2018

Expansion of cytotoxic CD3+ CD56+ cells from peripheral blood progenitor cells of patients undergoing autologous hematopoietic cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705503

21 January 2018

Use of a SCID mouse/human lymphoma model to evaluate cytokine-induced killer cells with potent antitumor cell activity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705503

21 January 2018

The antileukemia effect of HLA-matched NK and NK-T cells in chronic myelogenous leukemia involves NKG2D-target-cell interactions

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705503

21 January 2018

Engineering hematopoietic grafts: purified allogeneic hematopoietic stem cells plus expanded CD8+ NK-T cells in the treatment of lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705503

21 January 2018

Revealing lymphoma growth and the efficacy of immune cell therapies using in vivo bioluminescence imaging

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705503

21 January 2018

Visualizing the kinetics of tumor-cell clearance in living animals

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705503

21 January 2018

A phase I trial of autologous cytokine-induced killer cells for the treatment of relapsed Hodgkin disease and non-Hodgkin lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705503

21 January 2018

Antitumor activities of human autologous cytokine-induced killer (CIK) cells against hepatocellular carcinoma cells in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705503

21 January 2018

IL-2-activated cord blood mononuclear cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705503

21 January 2018

Ex vivo expanded umbilical cord blood T cells maintain naive phenotype and TCR diversity.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705503

21 January 2018

Novel adopted immunotherapy for mixed chimerism after unrelated cord blood transplantation in Omenn syndrome.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705503

21 January 2018

Role of NKG2D signaling in the cytotoxicity of activated and expanded CD8+ T cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705503

21 January 2018

HSV-TK gene transfer into donor lymphocytes for control of allogeneic graft-versus-leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705503

21 January 2018

Administration of herpes simplex-thymidine kinase-expressing donor T cells with a T-cell-depleted allogeneic marrow graft

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705503

21 January 2018

Herpes simplex thymidine kinase gene-transduced donor lymphocyte infusions

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705503

21 January 2018

Initial depletion of regulatory T cells: the missing solution to preserve the immune functions of T lymphocytes designed for cell therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705503

21 January 2018

Transplants of Umbilical-Cord Blood or Bone Marrow from Unrelated Donors in Adults with Acute Leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705503

21 January 2018

Cord-blood transplantation in patients with leukemia--a real alternative for adults

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705503

7 January 2021

based on heuristic

inferred from DOI database lookup

Expansion of cytolytic CD8(+) natural killer T cells with limited capacity for graft-versus-host disease induction due to interferon gamma production

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705503

7 January 2021

based on heuristic

inferred from DOI database lookup

Generation of cytokine-induced killer cells from leukaemic samples with in vitro cytotoxicity against autologous and allogeneic leukaemic blasts

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705503

7 January 2021

based on heuristic

inferred from DOI database lookup

Autologous cytokine-induced killer cell therapy in clinical trial phase I is safe in patients with primary hepatocellular carcinoma.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705503

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.BMT.1705503

1 reference

Europe PubMed Central

19 September 2017

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

19 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40287632&oldid=1893480687"